IRIS
AGUENNOUZ, M'hammed
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 13.775
NA - Nord America 10.780
AS - Asia 6.875
SA - Sud America 2.506
AF - Africa 249
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 11
AN - Antartide 1
Totale 34.208
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.576
RU - Federazione Russa 6.736
SG - Singapore 3.029
BR - Brasile 2.171
CN - Cina 1.961
IE - Irlanda 1.583
SE - Svezia 1.357
IT - Italia 1.182
DE - Germania 744
HK - Hong Kong 699
UA - Ucraina 512
FR - Francia 477
FI - Finlandia 415
VN - Vietnam 391
GB - Regno Unito 273
IN - India 183
PL - Polonia 173
AR - Argentina 117
CA - Canada 94
BD - Bangladesh 82
BE - Belgio 76
IQ - Iraq 70
TR - Turchia 68
ZA - Sudafrica 67
EC - Ecuador 65
MX - Messico 63
AT - Austria 58
ID - Indonesia 51
PK - Pakistan 46
MA - Marocco 45
UZ - Uzbekistan 45
CO - Colombia 43
CI - Costa d'Avorio 42
JP - Giappone 42
NL - Olanda 40
VE - Venezuela 34
CZ - Repubblica Ceca 32
CL - Cile 30
ES - Italia 25
KE - Kenya 22
AZ - Azerbaigian 21
PY - Paraguay 21
SA - Arabia Saudita 20
EG - Egitto 18
KZ - Kazakistan 17
NP - Nepal 17
TN - Tunisia 16
DZ - Algeria 14
LT - Lituania 14
MY - Malesia 14
IR - Iran 13
IL - Israele 12
LB - Libano 12
PE - Perù 11
PH - Filippine 11
AE - Emirati Arabi Uniti 10
AL - Albania 10
DO - Repubblica Dominicana 9
UY - Uruguay 9
EU - Europa 8
JM - Giamaica 8
PT - Portogallo 8
AU - Australia 7
CR - Costa Rica 7
KG - Kirghizistan 7
OM - Oman 7
RO - Romania 7
TH - Thailandia 7
BG - Bulgaria 6
HN - Honduras 6
JO - Giordania 6
PS - Palestinian Territory 6
RS - Serbia 6
SN - Senegal 6
BO - Bolivia 5
CH - Svizzera 5
GR - Grecia 5
NI - Nicaragua 5
SK - Slovacchia (Repubblica Slovacca) 5
TW - Taiwan 5
KH - Cambogia 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
PA - Panama 4
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
GA - Gabon 3
GT - Guatemala 3
HR - Croazia 3
KR - Corea 3
LV - Lettonia 3
NG - Nigeria 3
QA - Qatar 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
CY - Cipro 2
EE - Estonia 2
ET - Etiopia 2
GE - Georgia 2
HU - Ungheria 2
Totale 34.177
Salva come PNG Salva come JPEG
Città #
Moscow 2.071
Dublin 1.582
Singapore 1.513
Ashburn 1.428
Dallas 1.371
Chandler 1.092
Jacksonville 1.061
Nyköping 830
Beijing 710
Hong Kong 699
San Jose 463
The Dalles 381
Messina 360
Princeton 295
Los Angeles 272
Medford 272
Munich 251
Lauterbourg 246
Cambridge 242
Ann Arbor 241
Des Moines 212
Dearborn 172
São Paulo 164
Warsaw 157
New York 131
Buffalo 128
Boardman 127
Ho Chi Minh City 127
Helsinki 91
Tianjin 88
Jinan 82
Wilmington 78
Shenyang 75
Hanoi 70
Rio de Janeiro 68
Brussels 67
San Mateo 66
Turku 66
Woodbridge 63
Council Bluffs 62
Frankfurt am Main 61
Redondo Beach 61
Rome 61
Guangzhou 60
Lancaster 60
Belo Horizonte 59
Orem 56
Hyderabad 49
Nanjing 49
Brooklyn 47
Santa Clara 47
Bremen 44
Abidjan 41
Tashkent 40
Tokyo 40
Vienna 40
Curitiba 39
Pune 38
Seattle 37
Hebei 36
Houston 36
Nuremberg 35
Shanghai 35
Porto Alegre 32
Brasília 31
London 30
Ningbo 30
Johannesburg 29
Chennai 28
Zhengzhou 28
Hangzhou 27
Salvador 27
Taizhou 27
Atlanta 26
Caltagirone 26
Haikou 26
Milan 26
Montreal 26
Catania 25
Campinas 24
Dong Ket 24
Guarulhos 24
Guayaquil 24
Norwalk 24
Quito 23
Baghdad 22
Toronto 22
Baku 21
Falls Church 21
Mumbai 21
Nairobi 21
Amsterdam 20
Brno 20
Denver 20
Düsseldorf 20
San Francisco 20
Changsha 19
Ottawa 19
Phoenix 19
Ribeirão Preto 19
Totale 19.436
Salva come PNG Salva come JPEG
Nome #
Idrocefalo normoteso idiopatico (iNPH): nostra esperienza preliminare. 462
A NOVEL SERUM MICRORNA SIGNATURE TO SCREEN TRANSTHYRETIN-RELATED FAMILIAL AMYLOID POLYNEUROPATHY 362
Clinical and pathological features of focal myositis 248
A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular Dystrophy 245
4-Methyl umbelliferone effects on cell proliferation in human glioma cells. 240
SIRT1 and SIRT2 Expression correlates with advanced disease and bone lesions in Multiple Myeloma 240
PDXK mutations cause polyneuropathy responsive to pyridoxal 5'-phosphate supplementation. 236
MiRNA expression profiling regulates necroptotic cell death in hepatocellular carcinoma 234
Mutations in the Neuronal Vesicular SNARE VAMP2 Affect Synaptic Membrane Fusion and Impair Human Neurodevelopment 231
A Nouvel serum MicroRNA signature to screen ATTR 225
Circulating miRNAs expression as potential biomarkers of mild traumatic brain injury 216
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis 215
A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol 214
Analisi dello stato di metilazione del promoter di O6-methylguanine DNA methyltransferase (MGMT) e TMS1/ASC nei gliomi cerebrali diffusi di basso grado: possibili implicazioni cliniche e prognostiche. 214
A cytochemical study of apoptosis in metabolic myopathies 206
A life threatening case of β-enolase deficiency 200
MDR-1 gene polymorphisms G2677T and C3435T in a case of Hodgkin's variant of Richter's syndrome 198
Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects 197
microRNA-10 and -221 modulate differential expression of Hippo signaling pathway in human astroglial tumors 194
Modulation of neuronal nitric oxide synthase and apoptosis by the isoflavone genistein in Mdx mice 193
miRNA regulation of Sirtuin-1 expression in human astrocytoma 192
A homozygous MED11 C-terminal variant causes a lethal neurodegenerative disease 189
Hippo signaling pathway is altered in Duchenne muscular dystrophy 186
Effect of exercise on telomere length and telomere proteins expression in mdx mice 186
Characterization and functional analysis of the human microRNA 363 in glioblastoma transfected cell lines 181
Autoimmunity to heterogeneous nuclear ribonucleoprotein A1 in psoriatic patients and correlation with disease severity 181
NLRP3 inflammasome CSF expression and neuropsychological changes in idiopathic normal pressure hydrocephalus 180
Analisi dello stato di metilazione del promoter di O6-methylguanine DNA methyltransferase (MGMT) e TMS1/ASC: possibili implicazioni cliniche e prognostiche nei gliomi cerebrali diffusi di basso grado 178
Prognostic value of HMGB1 and oxidative stress markers in multiple trauma patients: A single-centre prospective study 178
(+)-Lipoic Acid Reduces Lipotoxicity and Regulates Mitochondrial Homeostasis and Energy Balance in an In Vitro Model of Liver Steatosis 178
A case of vacuolar myopathy during the course of chronic hepatitis C. 176
ANT1 is reduced in sporadic inclusion body myositis. 175
Expression of the tumor necrosis factor receptor-associated factors I and 2 and regulation of the nuclear factor-kappa B antiapoptotic activity in human gliomas 175
A novel variant of GALC in a familial case of Krabbe disease: Insights from structural bioinformatics and molecular dynamics simulation 174
ANT1 expression and RAGE-NF-kB pathway activation in sporadic inclusion-body myositis 174
Role of inflammation and oxidative stress mediators in gliomas. 172
Analysis of lipid profile in lipid storage myopathy 169
Analysis of HBV integration in mitochondrial DNA of HepAD38 cells by the high-throughput HBV integration sequencing and RNASeq approaches 168
ANT1 expression and RAGE-NF-kB pathway in sporadic inclusion body myositis. 168
MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation 168
Pilot study of flavocoxid in ambulant DMD patients. 167
Espressione differenziale di un panel di miRNA in tumori cerebrali astrogliali con diverso grado di malignità. 167
Type I Hyperprolinemia Associated with Epilepsy and Mental Retardation Results from PRODH Gene Mutations in Three Sicilian Children. 166
Asymptomatic hyperCKemia in a case of Danon disease due to a missense mutation in Lamp-2 gene 164
Activation of nuclear factor-kappa B in inflammatory myopathies and Duchenne muscular dystrophy 164
MicroRNA signatures predict dysregulated Vitamin D receptor and calcium pathways status in Limb Girdle muscle dystrophies (LGMD) 2A/2B. 163
Modulation of neural nitric oxide synthase by the isoflavone genistein promotes muscle regeneration in mdx mice 163
NfL as a biomarker in ATTRv amyloidosis: potential and limitations 161
Type I hyperprolinemia and proline dehydrogenase (PRODH) mutations in four Italian children with epilepsy and mental retardation. 160
Methylome Analysis in Nonfunctioning and GH-Secreting Pituitary Adenomas 159
Ant1 expression and RAGE-NF-kB pathway activation in sporadic inclusion body myositis 159
Activation of nuclear factor-κB in inflammatory myopathies and Duchenne muscular dystrophy 153
Fatal R631C mutation is also present in the adult form of CPTII deficiency 151
Clinical and genetic characterization in two families with muscle phosphofructokinase deficiency 151
Expression of telomeric repeat binding factor-1 in astroglial bran tumors 149
Clinical, biochemical and genetic features in muscle phosphofructokinase deficiency 149
Meccanismi anti-apoptotici nei gliomi. Ruolo dell'attività nucleare del nuclear factor-kb e dei suoi fattori di controllo. 149
Pilot study of flavocoxid in ambulant DMD patients. 149
A rare PANK2 deletion in the first north African patient affected with pantothenate kinase associated neurodegeneration 149
Recurrent rhabdomyolysis due to muscle β-enolase deficiency: very rare or underestimated? 149
Pilot study of flavocoxid in ambulant DMD patients. 149
Activation of NF-kappaB pathway in Duchenne muscular dystrophy: relation to age 149
Expression of transglutaminase 2 does not differentiate focal myositis from generalized inflammatory myopathies 147
Charcot-Marie-Tooth disease: experience from a large Italian tertiary neuromuscular center 147
Miopatie metaboliche 146
MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: an impact on susceptibility and prognosis. 146
Severe rhabdomyolysis in a patient with “Heat Stroke” 146
ANT1 expression and RAGE-NF-kB pathway in sporadic inclusion body myositis 146
Clinical and genetic charactherization in two families with muscle phosphofructokinase deficiency 145
Meccanismi antiapoptotici nf-kb-mediati in gliomi umani in vivo. 145
Mutations in NKX6-2 Cause Progressive Spastic Ataxia and Hypomyelination 144
MicroRNAs expression in pituitary tumors: differences related to functional status, pathological features, and clinical behavior 144
Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial 143
Activation and localization of transcription factor NF-KB in peripheral neuropathies of different origin. 142
Matrix Metalloproteinase 9 and Transglutaminase 2 Expression at the Ocular Surface in Patients with Different Forms of Dry Eye Disease 142
Sarcoglycans in cerebral cortex of the rat: an immunohistochemical and molecular study. 141
AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders 141
Biallelic mutations in neurofascin cause neurodevelopmental impairment and peripheral demyelination 139
Telomere shortening is associated to TRF1 and PARP1 overexpression in Duchenne muscular dystrophy 139
Telomere shortening and telomere-associated proteins in Duchenne muscular dystrophy. 138
Inverse correlation between TRF-1 (telomeric-repeat binding factor 1) and histological grade of malignant brain tumors 137
Calpain 3 deficiency in Quail Eater's disease 137
Clinical features and new molecular findings in muscle phosphofructokinase deficiency (GSD type VII). 137
miR-21 and 221 upregulation and miR-181b downregulation in human grade II-IV astrocytic tumors 136
Clinical heterogeneity and molecular basis of myoadenilate deaminase deficiency 135
Espressione del telomeric Repeat Binding Factor-1 (TRF-1) nei tumori cerebrali della serie astrogliale: possibili implicazioni clinico-terapeutiche. 134
Bi-allelic genetic variants in the translational GTPases GTPBP1 and GTPBP2 cause a distinct identical neurodevelopmental syndrome 133
Espressione di ANT1 e attivazione della via RAGE-NF-kB nella miosite a corpi inclusi. 133
Evidence of calpain and caspase-3-like activation in CSF of severe human traumatic brain injury 132
Meccanismi antiapoptotici NF-kB-mediati in gliomi umani in vivo. 132
CXCL12/CXCR4 axis supports mitochondrial trafficking in tumor myeloma microenvironment 130
Expression of the trascription factor NFkB in different muscular dystrophies 128
study of flavocoxid in ambulant DMD patients. 128
Implication of SIRT1 and its downstream pathways in dystrophic process. 128
Differential expression of Hippo signaling pathway in human astroglial tumors 127
Meningiomas and proteomics: Focus on new potential biomarkers and molecular pathways 127
Dyscondrosteosis in a child with Becker muscular dystrophy: an unreported association between Xp21 gene (DMD/BMD) deletion and a novel homozygous SHOX gene mutation 126
Studio dell'espressione genica della metalloproteinasi 3 e degli inibitori TIMP-1 e TIMP-2 nei meningiomi cerebrali 124
Novel SHOX Gene Mutation in a Short Boy with Becker Muscular Dystrophy: Double Trouble in Two Adjacent Genes. 123
Late-onset mitochondrial neuromyopathy: an age-related phenomenon ? 123
Totale 16.949
Salva come PNG Salva come JPEG
Categoria #
all - tutte 110.362
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.362
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021445 0 0 0 0 0 0 0 0 0 253 115 77
2021/20221.844 14 232 31 72 96 27 138 82 35 234 238 645
2022/20234.485 371 381 232 321 348 423 72 258 1.903 17 107 52
2023/20241.196 90 186 77 92 119 220 37 79 12 92 27 165
2024/20255.928 108 61 114 333 279 184 148 1.317 1.403 354 607 1.020
2025/202615.929 871 1.234 1.419 1.160 1.198 3.537 2.087 1.867 1.962 594 0 0
Totale 34.682